On December 13th, 2018 Steven Klein, Vice President, Business Development at IRICoR, will take part in a discussion session as a guest speaker at Genesis 2018 in London. As part of the 18th Annual Genesis Conference, Steven Klein will be one of over 70 expert speakers and panellists will lead sessions discussing which approaches will deliver better outcomes for patients, investors and payers. Along with Mr. Richard Butt from Apollo Therapeutics, Mark Samuels from Medicines Discovery Catapult and Mr Simon Saxby from Leaf Expression System, Steven will discuss the Evolving Models of R&D Collaboration.
To learn more about the conference’s program, click here.